Washington State Has Garnered Over $5 Billion in Marijuana Tax Revenue Since 2014

Since the legalization of recreational marijuana in Washington State in 2012, and the commencement of legal sales in July 2014, the state has witnessed an impressive boom in its marijuana market.

Over the past decade, this market has generated approximately $15 billion in total sales, according to the state’s Liquor and Cannabis Control Board. These sales resulted in over $5.5 billion in tax revenue for the state. This revenue has been made possible largely due to Washington’s 37% excise tax on marijuana sales—the highest in the nation.

In 2023 alone, Washington’s marijuana sales reached about $1.25 billion. As of July 2024, the state had already recorded $701.85 million in sales, with July being the most lucrative month, bringing in over $103 million. This consistent performance keeps Washington among the top states in the U.S. for legal marijuana sales.
Continue reading

DNC Releases 2024 Platform to be Voted on at Convention, Includes Multiple Marijuana Provisions

Today, the Democratic National Committee (DNC) released the final 2024 Democratic Party Platform, which will be voted on by delegates at the Convention tomorrow evening.

This platform was passed by the Platform Committee on July 16, before the President stepped aside. It will receive a final vote tomorrow at the DNC Convention. A section of the platform states:

“No one should be in jail just for using or possessing marijuana. Sending people to prison for possession has upended too many lives and incarcerated people for conduct that many states no longer prohibit. Those criminal records impose needless barriers to employment, housing, and educational opportunities, disproportionately affecting Black and brown people. President Biden took historic action to end this failed approach by pardoning people convicted federally for using or possessing marijuana. He has called on governors to use their pardon power to do the same for state-level offenses. And his Administration is taking a major step to reschedule cannabis so it’s no longer classified as more dangerous than fentanyl or methamphetamine.”
Continue reading

Colorado Finalizes Legal Psilocybin Rules

Colorado has officially established the rules for psilocybin use, paving the way for the state’s upcoming therapeutic program.

Although healing centers won’t begin administering psilocybin treatments until 2025, the state took a significant step forward by finalizing the regulations last week.

Tasia Poinsatte, the Colorado director of the Healing Advocacy Fund, which played a crucial role in launching Oregon’s psilocybin program four years ago, said their now actively involved in guiding Colorado’s efforts. Unlike some other psilocybin programs, Colorado’s regulations do not permit patients to take psilocybin products at home; instead, the treatments will be administered by licensed facilitators at designated healing centers.
Continue reading

Poll Finds Large Majority of Americans Support Expunging Marijuana Charges

A recent YouGov poll reveals that a significant majority of Americans support expunging the records of those convicted of marijuana-related offenses.

The survey, conducted this month, found that 61% of respondents are in favor of clearing the records for individuals with past marijuana charges, reflecting a growing shift in public opinion on drug-related criminal justice reform.

This support crosses party lines, with 71% of Democrats and 55% of independents backing the idea, while Republicans are nearly split, with 48% in favor. The poll highlights a broader trend in American attitudes toward marijuana, as more states legalize the substance for recreational and medicinal use; at the time of publication 24 states have legalized marijuana, with three others voting on the issue this November.
Continue reading

Both North and South Dakota Could Legalize Marijuana This November: A Look at the Two Initiatives

As November approaches, both North and South Dakota find themselves at pivotal moments in their respective paths toward marijuana legalization.

Voters in both states will have the opportunity to decide on measures that would legalize recreational marijuana for everyone 21 and older.

In North Dakota, Measure 5 would allow for the possession and use of up to one ounce of marijuana, four grams of marijuana concentrates, 1,500mg of THC in the form of cannabinoid products, and 300mg of edibles.
Continue reading

VA Medicinal Cannabis Research Act Gains 21st Sponsors in US Congress

The VA Medicinal Cannabis Research Act, legislation that seeks to advance research into the potential benefits of medical cannabis for veterans, has gained its 21st sponsor in the U.S. Congress.

On August 9, Congressmember Jason Crow (D-CO) signed on as a cosponsor of the House version of the bill, bringing the total number of sponsors in the US House of Representatives to 12. The Senate version of the bill currently has 12 sponsors, making for a combined total of 21 supporters in Congress. Congressmember Zoe Lofgren (D-CA) was the most recent new cosponsor prior to Crow. Lofgren signed on July 9.

The bill, introduced by Congressmember Lou Correa (D-CA) in the House (H.R. 1003) and by Senator Jon Tester (D-MT) in the Senate (S. 326), mandates the Department of Veterans Affairs (VA) to conduct clinical trials on the safety and efficacy of cannabis in treating veterans diagnosed with conditions such as chronic pain and post-traumatic stress disorder (PTSD). The legislation would also require the VA to submit reports on its findings to Congress, paving the way for informed policy decisions based on empirical evidence.
Continue reading

Teamsters Unionize 10th Marijuana Store in Illinois

Teamsters have successfully unionized their 10th marijuana store in Illinois.

teamsters 777Earlier this week, Teamsters Local 777 announced that they’ve won both a new collective bargaining agreement and an election at Zen Leaf in less than one week. Zen Leaf is a subsidiary of the multi-state operator Verano Holdings.

This accomplishment is the fourth Verano store in Illinois to unionize under the Teamsters. The push for unionization has been gaining momentum across the state in recent months, with six other Illinois cannabis stores voting to unionize earlier this year, bringing the total unionized marijuana stores in the state to at least 10.
Continue reading

Study: Nightly CBD Use for Insomnia Found Safe, Preserves Daytime Cognitive Function

A new study published in the journal Psychopharmacology shows that cannabidiol (CBD) may be useful as a sleep aid for individuals suffering from insomnia.

Conducted by researchers from Swinburne University of Technology and the Institute for Breathing and Sleep at Austin Hospital, the randomized controlled pilot trial explored whether nightly use of CBD impacts daytime neurocognitive performance. The study was published online ahead of print by the US National Library of Medicine.

The study involved 30 participants with primary insomnia, who were randomly assigned to receive either 150 mg of CBD or a placebo each night for two weeks. Before the double-blind dosing period, a single-blind placebo run-in week was conducted. The researchers assessed various cognitive functions, including attention, executive function, reasoning, information processing, and memory, using the CogPro system. These assessments were performed at the start of the trial, after one week, and at the trial’s conclusion.
Continue reading

Clinical Trial Finds Marijuana Capsules Effective in Reducing Chemotherapy-Induced Nausea and Vomiting

A new study published in the Journal of Clinical Oncology reveals that marijuana capsules containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) significantly reduces chemotherapy-induced nausea and vomiting in patients who have not responded to standard antiemetic treatments.

Marijuana capsules.

This randomized, placebo-controlled, phase II/III trial, conducted across 19 hospitals and universities in Australia, is one of the most comprehensive studies to date on the subject.

The study aimed to assess the efficacy of THC capsules as an adjunct treatment for adults suffering from nausea and vomiting during moderately or highly emetogenic chemotherapy, despite receiving guideline-consistent antiemetic prophylaxis. The trial included 147 participants who were given either the THC capsules or a placebo, in addition to their standard antiemetic medication during the first cycle of chemotherapy.
Continue reading

Vermont Recorded Over $66 Million in Marijuana Sales in First Half of 2024, Nearly $10 Million in Taxes

Vermont’s legal marijuana market generated over $66 million in revenue between January and June of this year.

(Photo credit: USA Today).

In the first half of 2024, Vermont’s licensed marijuana stores sold $66.22 million worth of marijuana and marijuana products, resulting in approximately $8.5 million in tax revenue, according to data compiled and released by the Vermont Department of Taxes.

The monthly high for the year was in May, with $11.45 million in sales generating $1.60 million in taxes. June followed with $11.14 million in sales, resulting in $1.56 million in tax revenue.”

Continue reading